Capabilities

About ANALYTICA MEDICAL, INC

Advancing Healthcare
through Cutting-Edge
Research

Analytica Medical, Inc. is a leading provider of clinical research services that bridges the gap between Clinical Research Organizations, community doctors, and their patients to advance science and better societal health.

Our mission is to reach the unreachable in healthcare research, especially for chronic diseases that have been long-standing challenges for physicians, healthcare providers, and patients.

get in touch

what we are offering

Excellence Delivered,
Services Offered

At Analytica Medical, we offer a range of clinical research services
tailored to meet the unique needs of our clients, including

pharmaceutical research

device validation

PAST PERFORMANCE

Delivering Results, Backed by History

Our team of professionals are certified industry experts dedicated to advancing science and improving patient care. With over two decades of experience, we have completed numerous successful projects, including

Protocol No. ALT-601-201

Phase 2, Double-blind, Randomized, Placebo-controlled Study of NasoVAX in the Prevention of Clinical Worsening in Patients with Early Coronavirus Infectious Disease 2019 (COVID-19)

R10933-10987-COV-20145

A Phase 2 study to Asses the Efficacy, Safety, and Tolerability Of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection

Protocol No. ALT-601-201

Phase 2, Double-blind, Randomized, Placebo-controlled Study of NasoVAX in the Prevention of Clinical Worsening in Patients with Early Coronavirus Infectious Disease 2019 (COVID-19)

J2W-MC-PYAB

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants with Mild to Moderate COVID-19 Illness

Clinical Performance Evaluation of a Point of Care Test to Detect Antibodies to SARS-CoV-2

R10933-10987-COV-2069

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

R10933-10987-COV-2067

A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (s) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19

A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection.

ANALYTICA MEDICAL, INC

DIVERSITY,
EQUITY + INCLUSION

We value diversity, equity, and inclusion in all aspects of our operations, and we prioritize DEI in our research initiatives by ensuring inclusive representation and access for underrepresented populations. Our commitment to DEI helps us to improve the quality and relevance of our research and ultimately improve patient outcomes.

At Analytica Medical, we are committed to providing high-quality, reliable, and efficient clinical research services that advance science and improve societal health.

get in touch